• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不平衡的 MYC 断裂分离 FISH 模式表明 HGBCL-DH-BCL2 中存在 MYC 重排。

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

机构信息

Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.

出版信息

Blood. 2024 Oct 10;144(15):1611-1616. doi: 10.1182/blood.2024025603.

DOI:10.1182/blood.2024025603
PMID:39133931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11487639/
Abstract

Fluorescence in situ hybridization (FISH) using break-apart probes is recommended for identifying high-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2). Unbalanced MYC break-apart patterns, in which the red or green signal is lost, are commonly reported as an equivocal result by clinical laboratories. In a cohort of 297 HGBCL-DH-BCL2, 13% of tumors had unbalanced MYC break-apart patterns with loss of red (LR; 2%) or loss of green (LG; 11%) signal. To determine the significance of these patterns, MYC rearrangements were characterized by sequencing in 130 HGBCL-DH-BCL2, including 3 LR and 14 LG tumors. A MYC rearrangement was identified for 71% of tumors with LR or LG patterns, with the majority involving immunoglobulin loci or other recurrent MYC rearrangement partners. The architecture of these rearrangements consistently preserved the rearranged MYC allele, with the MYC gene predicted to be on the derivative chromosome containing the signal that is still present in nearly all cases. MYC protein expression, MYC messenger RNA expression, and the proportion of tumors expressing the dark-zone signature was not significantly different between balanced and unbalanced groups. These results support a recommendation that unbalanced MYC break-apart FISH patterns be reported as positive for MYC rearrangement in the context of diagnosing HGBCL-DH-BCL2.

摘要

荧光原位杂交(FISH)使用分离探针,推荐用于识别具有 MYC 和 BCL2 重排的高级别 B 细胞淋巴瘤(HGBCL-DH-BCL2)。临床实验室通常将不平衡的 MYC 分离模式(红色或绿色信号丢失)报告为不确定结果。在 297 例 HGBCL-DH-BCL2 队列中,13%的肿瘤具有不平衡的 MYC 分离模式,表现为红色(LR;2%)或绿色(LG;11%)信号丢失。为了确定这些模式的意义,对 130 例 HGBCL-DH-BCL2 中的 MYC 重排进行了测序,包括 3 例 LR 和 14 例 LG 肿瘤。LR 或 LG 模式的肿瘤中 71%鉴定出 MYC 重排,大多数涉及免疫球蛋白基因座或其他常见的 MYC 重排伙伴。这些重排的结构始终保留了重排的 MYC 等位基因,MYC 基因预测位于含有信号的衍生染色体上,在几乎所有情况下,该信号仍然存在。平衡和不平衡组之间 MYC 蛋白表达、MYC 信使 RNA 表达和表达暗区特征的肿瘤比例没有显著差异。这些结果支持在诊断 HGBCL-DH-BCL2 时,将不平衡的 MYC 分离 FISH 模式报告为 MYC 重排阳性的建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cc/11487639/59294eb53ab0/BLOOD_BLD-2024-025603-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cc/11487639/59294eb53ab0/BLOOD_BLD-2024-025603-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cc/11487639/59294eb53ab0/BLOOD_BLD-2024-025603-ga1.jpg

相似文献

1
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.不平衡的 MYC 断裂分离 FISH 模式表明 HGBCL-DH-BCL2 中存在 MYC 重排。
Blood. 2024 Oct 10;144(15):1611-1616. doi: 10.1182/blood.2024025603.
2
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).发病机制和影响因素:MYC 和 BCL2 重排的高级别 B 细胞淋巴瘤中的 MYC 重排(一项 LLMPP 研究)。
Blood. 2024 Aug 1;144(5):525-540. doi: 10.1182/blood.2024024251.
3
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.B细胞受体沉默揭示了伴有MYC和BCL2重排的高级别B细胞淋巴瘤的起源及依赖性
Blood Cancer Discov. 2025 Jul 1;6(4):364-393. doi: 10.1158/2643-3230.BCD-25-0099.
4
Comparative investigation among fluorescence in situ hybridization, DNA- and RNA-sequencing on detecting MYC, BCL2, and BCL6 rearrangements in high-grade B-cell lymphomas.荧光原位杂交、DNA 和 RNA 测序在高级别 B 细胞淋巴瘤中检测 MYC、BCL2 和 BCL6 重排的比较研究。
Neoplasma. 2024 Oct;71(5):490-497. doi: 10.4149/neo_2024_240527N236.
5
CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.伴有MYC和BCL2重排及表达暗区特征的弥漫性大B细胞淋巴瘤的中枢神经系统复发。
Blood. 2025 Feb 6;145(6):590-596. doi: 10.1182/blood.2024025725.
6
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.嵌合抗原受体T细胞(CAR-T)挽救治疗后高级别B细胞淋巴瘤与其他大B细胞淋巴瘤的结局:一项DESCAR-T LYSA研究
Blood Adv. 2025 May 27;9(10):2500-2510. doi: 10.1182/bloodadvances.2024014732.
7
Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.一位患有伴有MYC、BCL6和BCL2基因座异常的高级别B细胞淋巴瘤患者出现意外良好转归。
Cancer Genet. 2018 Apr;222-223:25-31. doi: 10.1016/j.cancergen.2018.01.003. Epub 2018 Feb 3.
8
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients.儿科和青年患者中 MYC 重排 B 细胞淋巴瘤的细胞遗传学和病理学特征。
J Hematop. 2024 Jun;17(2):51-61. doi: 10.1007/s12308-024-00579-6. Epub 2024 Apr 2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.

引用本文的文献

1
"In situ" MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration.“原位”MYC重排和扩增作为11q异常的高级别B细胞淋巴瘤病例中的继发性改变。
Ann Hematol. 2025 Aug 7. doi: 10.1007/s00277-025-06433-8.
2
High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R.未特指的高级别 B 细胞淋巴瘤,以原发性腹膜淋巴瘤形式出现,经剂量调整的 EPOCH-R 治疗后成功缓解。
J Clin Exp Hematop. 2024 Mar 28;64(1):37-44. doi: 10.3960/jslrt.23044. Epub 2024 Jan 28.
3
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.

本文引用的文献

1
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).发病机制和影响因素:MYC 和 BCL2 重排的高级别 B 细胞淋巴瘤中的 MYC 重排(一项 LLMPP 研究)。
Blood. 2024 Aug 1;144(5):525-540. doi: 10.1182/blood.2024024251.
2
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.利用全基因组测序分析揭示不平衡MYC断裂分离荧光原位杂交结果的基因组基础。
Blood Cancer J. 2023 Dec 19;13(1):190. doi: 10.1038/s41408-023-00967-8.
3
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
利用全基因组测序分析揭示不平衡MYC断裂分离荧光原位杂交结果的基因组基础。
Blood Cancer J. 2023 Dec 19;13(1):190. doi: 10.1038/s41408-023-00967-8.
复发时间与弥漫性大 B 细胞淋巴瘤的独特进化动力学相关。
J Clin Oncol. 2023 Sep 1;41(25):4164-4177. doi: 10.1200/JCO.23.00570. Epub 2023 Jun 15.
4
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.弥漫性大 B 细胞淋巴瘤真实世界人群中临床结局的分子决定因素。
Blood. 2023 May 18;141(20):2493-2507. doi: 10.1182/blood.2022018248.
5
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.伯基特淋巴瘤和高级别B细胞淋巴瘤的诊断方法及未来方向
Virchows Arch. 2023 Jan;482(1):193-205. doi: 10.1007/s00428-022-03404-6. Epub 2022 Sep 3.
6
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
7
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.成熟淋巴细胞肿瘤国际共识分类:临床咨询委员会报告。
Blood. 2022 Sep 15;140(11):1229-1253. doi: 10.1182/blood.2022015851.
8
MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma.MYC 断裂分离荧光原位杂交(FISH)探针组在评估侵袭性 B 细胞淋巴瘤时显示出频繁的意义未明的不平衡模式。
Blood Cancer J. 2021 Nov 24;11(11):184. doi: 10.1038/s41408-021-00578-1.
9
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing.GRIDSS2:利用单断点变体和结构变异相位进行体细胞结构变异的全面特征描述。
Genome Biol. 2021 Jul 12;22(1):202. doi: 10.1186/s13059-021-02423-x.
10
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.MYC和BCL2结构变异对弥漫性大B细胞淋巴瘤(DLBCL)形态肿瘤的影响及MYC免疫组化假阴性机制
Blood. 2021 Apr 22;137(16):2196-2208. doi: 10.1182/blood.2020007193.